WANA (Nov 11) – Iran has taken a major step toward pharmaceutical self-sufficiency, as the Dean of the Faculty of Pharmacy at Tehran University of Medical Sciences announced that most raw materials for anti-cancer drugs are now produced domestically by young experts and knowledge-based companies.

 

Dr. Mohsen Amini, Dean of the Faculty of Pharmacy, said in an interview with local media: “The development of Iran’s pharmaceutical industry is the result of strong academic education and close collaboration between universities and the industry. Today, we are capable of producing many modern anti-cancer drugs that are made with cutting-edge technologies worldwide.”

 

He explained that many pharmacy graduates join knowledge-based companies after completing their studies, where they turn innovative ideas from laboratory research into industrial-scale production.

According to Amini, the raw materials for more than 400 types of medicines — including many high-cost anti-cancer drugs — are now synthesized inside the country using advanced technologies such as chemical synthesis, biotechnology, and nanotechnology.

 

He emphasized that these achievements have significantly reduced the cost of treatment, noting that locally produced drugs are much more affordable than their imported counterparts. “Many Iranians living abroad even take domestically made medicines back with them when visiting family in Iran,” he added.

 

Amini concluded: “The success of Iran’s pharmaceutical industry demonstrates that investment in education, research, and homegrown technology can lead to self-sufficiency in the production of advanced medicines.”